24 members of Congress have disclosed 155 trades in Novartis Ag (NVS) since 2014: 78 purchases worth about $1.35M and 77 sales worth about $1.98M. The most active was Kevin Hern, with 3 trades. The latest trade was made on Aug 27, 2026.
NVS’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought NVS, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kevin HernR-OK | 3 | 1 | 2 | $8.00K | $40.50K | -$32.50K | -42.1% | Jul 27, 2020 | Aug 27, 2026 |
| 2 | Ro KhannaD-CA | 6 | 3 | 3 | $73.00K | $48.50K | +$24.50K | +4.0% | Apr 1, 2021 | Mar 13, 2026 |
| 3 | Lisa C. McClainR-MI | 10 | 5 | 5 | $40.00K | $40.00K | $0.00 | +13.8% | Jun 9, 2025 | Oct 31, 2025 |
| 4 | George WhitesidesD-CA | 1 | 0 | 1 | $0.00 | $175.00K | -$175.00K | – | Mar 24, 2025 | Mar 24, 2025 |
| 5 | Daniel S. GoldmanD-NY | 3 | 1 | 2 | $75.00K | $107.50K | -$32.50K | -8.2% | Feb 27, 2023 | Jul 10, 2023 |
| 6 | John H. RutherfordR-FL | 3 | 2 | 1 | $16.00K | $8.00K | +$8.00K | -69.4% | Jul 11, 2017 | Mar 16, 2022 |
| 7 | Donald S. Beyer, Jr.D-VA | 16 | 9 | 7 | $72.00K | $56.00K | +$16.00K | -48.7% | Nov 19, 2019 | Feb 28, 2022 |
| 8 | David P. RoeR-TN | 17 | 11 | 6 | $88.01K | $48.00K | +$40.00K | -48.8% | Jul 27, 2017 | Dec 31, 2020 |
| 9 | Alan S. LowenthalD-CA | 9 | 7 | 2 | $51.39K | $40.50K | +$10.89K | -74.0% | Nov 29, 2018 | Nov 23, 2020 |
| 10 | Francis RooneyR-FL | 6 | 4 | 2 | $32.00K | $16.00K | +$16.00K | -73.0% | Feb 7, 2017 | Aug 12, 2020 |
| 11 | Greg GianforteR-MT | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | -98.0% | Mar 18, 2020 | Mar 18, 2020 |
| 12 | Mikie SherrillD-NJ | 2 | 0 | 2 | $0.00 | $16.00K | -$16.00K | – | May 28, 2019 | Feb 20, 2020 |
| 13 | Van TaylorR-TX | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Mar 25, 2019 | Mar 25, 2019 |
| 14 | James B. RenacciR-OH | 15 | 10 | 5 | $312.01K | $205.00K | +$107.00K | -127.6% | Mar 15, 2015 | Sep 20, 2018 |
| 15 | Diane BlackR-TN | 11 | 2 | 9 | $107.50K | $404.00K | -$296.50K | -113.6% | Apr 16, 2015 | Jul 30, 2018 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kevin HernR-OK | NVSNovartis AG Common Stock | Self | Sell | $15K–$50K | Aug 27, 2026 | Sep 25, 2026 | 29d | +4.4% | +6.9% | |
| Ro KhannaD-CA | NVSNOVARTIS AG ADR SPONSORED ADR CMN | Spouse | Sell (Partial) | $1K–$15K | Mar 13, 2026 | Apr 7, 2026 | 25d | +5.2% | -8.3% | |
| Ro KhannaD-CA | NVSNOVARTIS AG-ADR SPONSORED ADR CMN | Spouse | Sell (Partial) | $1K–$15K | Feb 13, 2026 | Mar 9, 2026 | 24d | -1.0% | -11.3% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Sell | $1K–$15K | Oct 31, 2025 | Nov 21, 2025 | 21d | +30.4% | +20.2% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Buy | $1K–$15K | Oct 30, 2025 | Nov 21, 2025 | 22d | +31.7% | +21.1% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Sell | $1K–$15K | Oct 30, 2025 | Nov 21, 2025 | 22d | +31.7% | +21.1% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Sell (Partial) | $1K–$15K | Sep 25, 2025 | Oct 22, 2025 | 27d | +32.1% | +17.8% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Buy | $1K–$15K | Sep 11, 2025 | Oct 22, 2025 | 41d | +26.5% | +12.1% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Sell (Partial) | $1K–$15K | Jun 10, 2025 | Aug 13, 2025 | 64d late | +36.2% | +11.5% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Sell (Partial) | $1K–$15K | Jul 22, 2025 | Aug 13, 2025 | 22d | +38.2% | +18.6% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Buy | $1K–$15K | Jun 17, 2025 | Aug 13, 2025 | 57d late | +38.7% | +12.8% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Buy | $1K–$15K | Jun 11, 2025 | Aug 13, 2025 | 63d late | +36.8% | +11.7% | |
| Lisa C. McClainR-MI | NVSNovartis AG Common Stock | Spouse | Buy | $1K–$15K | Jun 9, 2025 | Aug 13, 2025 | 65d late | +36.8% | +11.4% | |
| George WhitesidesD-CA | NVSNovartis AG Common Stock | Self | Sell | $100K–$250K | Mar 24, 2025 | Apr 23, 2025 | 30d | +45.4% | +14.3% | |
| Ro KhannaD-CA | NVSNOVARTIS AG-ADR SPONSORED ADR CMN | Spouse | Buy | $1K–$15K | Feb 9, 2024 | Mar 6, 2024 | 26d | +59.8% | +9.8% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
24 members of Congress have disclosed 155 trades in Novartis Ag (NVS) since 2014: 78 purchases worth about $1.35M and 77 sales worth about $1.98M. The most active was Kevin Hern, with 3 trades. The latest trade was made on Aug 27, 2026. Most active: Kevin Hern (3), Ro Khanna (6), Lisa C. McClain (10), George Whitesides (1), Daniel S. Goldman (3).
Since 2014 they have disclosed 78 purchases and 77 sales; by the midpoints of the disclosed ranges, about $1.35M bought and $1.98M sold, a net sale of $636.11K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded NVS on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.